
Caldolor dosing was initiated pre-operatively and continued in the post-operative period.
Singla et al. Pain Medicine, 2010.
*Compared to placebo plus morphine. Results of a multi-center, randomized, double-blind placebo-controlled trial of patients undergoing total knee or hip replacement, reconstruction, or arthroplasty (N=185). Patients received 800 mg Caldolor or placebo preemptively and every 6 hours after surgery. All patients received intra-operative fentanyl; no other analgesia was given during surgery. Pain was assessed in the immediate post-operative period.
The most common adverse events reported in this clinical trial were nausea, vomiting, and constipation.
Efficacy: Abdominal Hysterectomy Pain · Efficacy: Dose Ranging Pain
CALDOLOR should be used with caution in patients with congestive heart failure, kidney impairment, at risk of blood clots, and in those who have a history of ulcers or gastrointestinal bleeding. When used in such patients, attention to using the lowest effective dose for the shortest time period is important to reduce the risk of serious adverse events. Ibuprofen has been associated with high blood pressure, serious skin reactions, and serious allergic reactions.
The most common adverse events reported in the controlled clinical trials were nausea, flatulence, vomiting, and headache.
CALDOLOR is indicated in adults for the management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics, and reduction of fever.
Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen
(IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Medicine. 2010;11:1284-1293.